Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Real-time Estimate Tradegate 05:13:56 2024-04-22 am EDT 5-day change 1st Jan Change
27.29 EUR +3.67% Intraday chart for Bayer AG +3.10% -18.88%
LockThis Alphavalue article, the European leader in independent research, is only available to subscribers .
Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!
Already a customer? Log In
JPMorgan rates Bayer at 'Neutral' - Target 34 euros DP
BAYER AG : JP Morgan remains Neutral ZD
Bayer Signs Renewable Energy Purchase Deal for Six German Sites MT
Bayer: signs renewable energy supply contract CF
Capgemini: new platform implemented for Bayer CF
TV ratings: Bayer's Europa League success brings RTL many viewers DP
Bayer’s Investigational Gene Therapy for Heart Failure Gets US FDA Fast Track Designation MT
AskBio receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart Failure CI
Bayer: fast-track procedure in cardiology in the USA CF
Study: US companies outpace Europe and Asia in research spending DP
Stifel Cuts Bayer PT, Keeps Hold Rating MT
Sat.1 to show top match between FC Bayern and Stuttgart DP
Conti slumps to early November level after figures DP
BAYER : Stifel lowers its target price CF
Bayer: presents results on Parkinson's disease CF
Bayer AG and Asklepios BioPharmaceutical, Inc Presents Results from the 18-Month Phase Ib Clinical Trial for AB-1005 CI
Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains RE
Eurozone Industrial Production Recovery Boosts German Stocks Amid Growing Tensions in Middle East MT
UBS Trims Bayer PT, Maintains Neutral Rating MT
BAYER AG : Barclays reaffirms its Neutral rating ZD
Nutrien Plans Exit From Argentina, Chile MT
BAYER : UBS lowers price target CF
BAYER AG : Gets a Neutral rating from JP Morgan ZD
BAYER : Another peer group tidy up Alphavalue
Bayer's patent for blood thinner Xarelto invalid, UK court rules RE
Chart Bayer AG
More charts
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
26.32 EUR
Average target price
37.05 EUR
Spread / Average Target
+40.73%
Consensus
  1. Stock Market
  2. Equities
  3. BAYN Stock
  4. News Bayer AG
  5. Bayer: Fresh money would be very welcome